BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kojima Y, Hirotsu Y, Omata W, Sugimori M, Takaoka S, Ashizawa H, Nakagomi K, Yoshimura D, Hosoda K, Suzuki Y, Mochizuki H, Omata M. Influence of NUDT15 variants on hematological pictures of patients with inflammatory bowel disease treated with thiopurines. World J Gastroenterol 2018; 24(4): 511-518 [PMID: 29398872 DOI: 10.3748/wjg.v24.i4.511]
URL: https://www.wjgnet.com/1007-9327/full/v24/i4/511.htm
Number Citing Articles
1
Apichaya Puangpetch, Rawiporn Tiyasirichokchai, Samart Pakakasama, Supaporn Wiwattanakul, Usanarat Anurathapan, Suradej Hongeng, Chonlaphat Sukasem. NUDT15 genetic variants are related to thiopurine-induced neutropenia in Thai children with acute lymphoblastic leukemiaPharmacogenomics 2020; 21(6): 403 doi: 10.2217/pgs-2019-0177
2
Sara van Gennep, Kadère Konté, Berrie Meijer, Martijn W. Heymans, Geert R. D’Haens, Mark Löwenberg, Nanne K. H. de Boer. Systematic review with meta‐analysis: risk factors for thiopurine‐induced leukopenia in IBDAlimentary Pharmacology & Therapeutics 2019; 50(5): 484 doi: 10.1111/apt.15403
3
Aswin Anand Pai, Ajith Mohan, Esther Sathya Bama Benjamin, Raveen Stephen Stallon Illangeswaran, Infencia Xavier Raj, Nancy Beryl Janet, Arun Kumar Arunachalam, ML Kavitha, Uday Kulkarni, Anup J Devasia, NA Fouzia, Aby Abraham, Alok Srivastava, Biju George, Vikram Mathews, Anu Korula, Poonkuzhali Balasubramanian. NUDT15 c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance TherapyPharmacogenomics and Personalized Medicine 2021; : 1303 doi: 10.2147/PGPM.S325813
4
Wenyu Jiang, Shasha Wu, Meijiao Lu, Jiahui Tian, Xiufang Cui, Xiaqiong Mao, Chunhua Jiao, Nana Tang, Jingjing Ma, Hongjie Zhang, Keiko Hosohata. NUDT15 Haplotypes and Diplotypes Predict Thiopurine-Induced Leukopenia and the Influence of Prolonged Exposure to Azathioprine on Hematologic Indices in Patients with Inflammatory Bowel DiseasesJournal of Clinical Pharmacy and Therapeutics 2023; 2023: 1 doi: 10.1155/2023/3000409
5
Motoki Makuuchi, Yoichi Kakuta, Junji Umeno, Toshimitsu Fujii, Tetsuya Takagawa, Takashi Ibuka, Miki Miura, Yu Sasaki, Sakuma Takahashi, Hiroshi Nakase, Hiroki Kiyohara, Keiichi Tominaga, Yosuke Shimodaira, Sakiko Hiraoka, Nobuhiro Ueno, Shunichi Yanai, Takeo Yoshihara, Kazuki Kakimoto, Katsuyoshi Matsuoka, Ryohei Hayashi, Sohachi Nanjo, Itaru Iwama, Yoh Ishiguro, Hirofumi Chiba, Katsuya Endo, Takashi Kagaya, Tomohiro Fukuda, Yasuhisa Sakata, Takahiro Kudo, Tomohisa Takagi, Kenichi Takahashi, Makoto Naganuma, Masaru Shinozaki, Noriyuki Ogata, Hiroki Tanaka, Kazuyuki Narimatsu, Haruka Miyazaki, Takashi Ishige, Motoyuki Onodera, Yu Hashimoto, Hiroshi Nagai, Yusuke Shimoyama, Takeo Naito, Rintaro Moroi, Hisashi Shiga, Yoshitaka Kinouchi, Akira Andoh, Tadakazu Hisamatsu, Atsushi Masamune. Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter studyJournal of Gastroenterology 2024;  doi: 10.1007/s00535-024-02099-7
6
Masahiro Nezu, Yosuke Hirotsu, Kenji Amemiya, Miho Katsumata, Tomomi Watanabe, Soichi Takizawa, Masaharu Inoue, Hitoshi Mochizuki, Kyoko Hosaka, Toshio Oyama, Masao Omata. A case of juvenile-onset pheochromocytoma with <i>KIF1B</i> p.V1529M germline mutationEndocrine Journal 2022; 69(6): 705 doi: 10.1507/endocrj.EJ21-0475
7
Sadia Afrin, Lisa A. Simms, Anton Lord, Graham L. Radford‐Smith. Nudix hydrolase 15 (NUDT15) loss‐of‐function variants in an Australian inflammatory bowel disease populationInternal Medicine Journal 2022; 52(11): 1971 doi: 10.1111/imj.15746
8
Shintaro Akiyama, Katsuyoshi Matsuoka, Kyoko Fukuda, Shunsuke Hamada, Mikiko Shimizu, Kosaku Nanki, Shinta Mizuno, Hiroki Kiyohara, Mari Arai, Shinya Sugimoto, Yasushi Iwao, Haruhiko Ogata, Tadakazu Hisamatsu, Makoto Naganuma, Maiko Motobayashi, Kohei Suzuki, Kento Takenaka, Toshimitsu Fujii, Eiko Saito, Masakazu Nagahori, Kazuo Ohtsuka, Mayumi Mochizuki, Mamoru Watanabe, Masayuki Hashiguchi, Takanori Kanai. Long‐term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurineJournal of Gastroenterology and Hepatology 2019; 34(10): 1751 doi: 10.1111/jgh.14693
9
Devendra Desai, Anuraag Jena, Vishal Sharma, Toshifumi Hibi. Time to incorporate preemptive NUDT15 testing before starting thiopurines in inflammatory bowel disease in Asia and beyond: a reviewExpert Review of Clinical Pharmacology 2023; 16(7): 643 doi: 10.1080/17512433.2023.2232300
10
Hitomi Okamoto, Yoichi Tanaka, Yoshio Shibagaki, Satoshi Kuronuma, Yusuke Miyatani, Satoko Umeda, Emi Mishiro-Sato, Osamu Takeuchi, Seisuke Hattori, Taku Kobayashi, Mitsuru Okuwaki. Measurement of the intracellular active metabolites of thiopurine drugs to evaluate the enzymatic activity of nudix hydrolase 15 in human blood samplesJournal of Chromatography B 2024; 1234: 123993 doi: 10.1016/j.jchromb.2024.123993
11
Yuki Nagakubo, Yosuke Hirotsu, Kenji Amemiya, Toshio Oyama, Hitoshi Mochizuki, Masao Omata. Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCRBMC Medical Genomics 2019; 12(1) doi: 10.1186/s12920-019-0610-8
12
Anastasia Konidari, David Dickens, Munir Pirmohamed. Inflammatory Bowel Disease: A Personalized ApproachFrontiers in Pediatrics 2021; 8 doi: 10.3389/fped.2020.620545
13
Jong Kwon Lee, Rihwa Choi, Soo-Youn Lee. NUDT15Genotyping in Thiopurine Drug TherapyLaboratory Medicine Online 2022; 12(4): 217 doi: 10.47429/lmo.2022.12.4.217